BP
PFE icon

Banyan Partners’s Pfizer PFE Stock Holding History

Banyan Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$10.3M Buy
365,366
+13,101
+4% +$368K 0.87% 30
2014
Q2 		$9.92M Buy
352,265
+9,314
+3% +$266K 0.84% 32
2014
Q1 		$10.5M Sell
342,951
-1,995
-0.6% -$59.5K 0.9% 27
2013
Q4 		$10M Buy
344,946
+118,486
+52% +$3.45M 0.7% 30
2013
Q3 		$6.17M Sell
226,460
-5,864
-3% -$160K 0.55% 41
2013
Q2 		$6.17M Buy
+232,324
New +$6.42M 1.22% 31

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Banyan Partners's PFE Position: Q3 2014 in Review

Banyan Partners increased its Pfizer (PFE) stake by 3.7% in Q3 2014, buying an estimated $368K and bringing the position to 365,366 shares worth $10.3M. The position accounts for 0.87% of the portfolio, ranked #30.

Banyan Partners first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. The position peaked at $10.5M in Q1 2014. 1,741 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Banyan Partners held 365,366 shares of Pfizer worth $10.3M as of Q3 2014.
  • Banyan Partners bought 13,101 Pfizer shares in Q3 2014, an estimated $368K.
  • Pfizer made up 0.87% of Banyan Partners's portfolio in Q3 2014, its #30 holding.
  • Banyan Partners first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
  • Banyan Partners's Pfizer position peaked at $10.5M in Q1 2014.
  • 1,741 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.